Global Blood Therapeutics Inc.

(GBT) Trade

By |

Profile

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.

Contact Information

Website: www.gbt.com
Email: investor@gbt.com
Main Phone: +1 650 741-7700
Address: 171 Oyster Point Boulevard
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Ted W. Love
Employees: 147
NAICS: Medicinal and Botanical Manufacturing(325411)
$ 42.24 $ -0.37 (-0.87%)
Last Price 42.24 Change $ -0.37 Change % -0.87 Tick N/A
Bid 40.61 Bid Size 100.00 Ask 44.52 Ask Size 500.00
Open 42.09 High 43.19 Low 41.55 Prev Close 42.61
Last Trade Volume 965,174 52 Wk Hi 68.05 52 Wk Low 30.15
Market Cap 2.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 52,232,448.00 EPS (TTM) -3.43 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 15 141
Number of Buys 9 75
Number of Sells 6 66
Net Activity -4800 104148
Last 10 Buys Shares
Edelman Joseph 1,000
John Schembri 1,000
Eleanor L. Ramos 1,000
Hing Sham 1,000
Peter Radovich 1,000
Mark L. Perry 1,000
Ted W. Love 1,000
Deval L. Patrick 1,000
John Schembri 1,000
Eleanor L. Ramos 1,000
Last 10 Sell Shares
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Lesley Ann Calhoun 1,000
Jung E. Choi 1,000
Jung E. Choi 1,000
Peter Radovich 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 83 83 83 83
Low Target Price Estimate 59 59 59 59
Mean Target Price Estimate 73 73 73 73
Standard Deviation 6.16 6.16 6.16 6.16
Date of Most Recent Estimate 05/24/18 05/24/18 05/22/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 9 9 10
Moderate Buy 1 1 1 2
Hold 1 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.27 1.27 1.13